| Note - The total numbers of organisms reported for this period are lower than expected, making us suspect that some have not been counted properly. Until and if this is resolved, please treat these data as preliminary. | ||||||||||||||||
| Antimicrobial Agent Abbreviations | ||||||||||||||||
| Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Quin-Dalf-Quinupristin-Dalfopristin, Tetra-Tetracycline, Tige-Tigecycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin | ||||||||||||||||
| PMC Outpatients, Jan-Dec 2008, Blood Isolates | ||||||||||||||||
| Percent Susceptible | ||||||||||||||||
| Organism | No | Amp or Pen | Cefaz | Clinda | Eryth | Gent | Naf | Tmp/Sxt | Levo | Tetra | Linz | Quin-Dalf | Vanco | |||
| Coagulase negative staphylococcus | 19 | 5 | 42 | 56 | 26 | 95 | 42 | 100 | 47 | 90 | 100 | 100 | 100 | |||
| PMC Outpatients, Jan-Dec 2008, Non-Urinary Isolates | ||||||||||||||||
| Percent Susceptible | ||||||||||||||||
| Organism | No | Amp of Pen | Amp/Sulb or Amox/Clav | Cefaz | Clinda | Ery | Gent | Naf | Tmp/Sxt | Levo | Tetra | Nitro | Linz | Quin-Dalf | Vanco | |
| S. aureus | 341 | 4 | 48 | 48 | 80 | 38 | 99 | 48 | 99 | 77 | 93 | nt | 100 | 99 | 100 | |
| Coagulase negative staphylococcus | 11 | 9 | 36 | 36 | 73 | 27 | 82 | 36 | nt | 54 | nt | nt | 100 | 100 | 100 | |
| Enterococcus sp | 33 | 85 | nt | nt | nt | 24 | nt | nt | nt | 64 | 39 | 78 | 88 | 18 | 85 | |
| Organism | No. | Amp | Amp/Sulb or Amox/Clav | Cefaz | Ceftaz | Cefep | Gent | Tobra | Levo | Mero (Imip) | Pip (Pip/Tazo) | Tmp/Sxt | ||||
| E. coli | 33 | 45 | 64 | 91 | 100 | 100 | 88 | 93 | 79 | 100 | 71(100) | 88 | ||||
| K. pneumoniae | 17 | 0 | 61 | 82 | 88 | 88 | 88 | 82 | 77 | 88 | 0(82) | 82 | ||||
| P. mirabilis | 26 | 100 | 100 | 96 | 100 | 100 | 100 | 100 | 96 | 100 | 100(100) | 100 | ||||
| P. aeruginosa | 53 | nt | nt | nt | 94 | 94 | 85 | 96 | 86 | 98 | 92 | nt | ||||
| PMC Outpatients, Jan-Dec 2008, Urinary Isolates | ||||||||||||||||
| Percent Susceptible | ||||||||||||||||
| Organism | No | Amp or Pen | Amox/Clav | Cefaz | Ery | Clinda | Gent | Naf | Nitro | Tmp/Sxt | Levo | Tetra | Linz | Quin-Dalf | Vanco | |
| S. aureus | 21 | 6 | 62 | 62 | 52 | 67 | 100 | 62 | 100 | 95 | 67 | 86 | 100 | 100 | 100 | |
| Coagulase negative staphylococcus | 78 | 5 | 28 | 28 | 36 | 73 | 71 | 29 | 99 | nt | 45 | nt | 97 | 100 | 100 | |
| Enterococcus sp | 158 | 93 | nt | nt | 16 | nt | nt | nt | 92 | nt | 75 | 25 | 95 | 10 | 92 | |
| Percent Susceptible | ||||||||||||||||
| Organism | No. | Amp | Amp/Sulb or Amox/Clav | Cefaz | Ceftaz | Cefp | Gent | Tobra | Amik | Levo | Norflox | Nitro | Pip (Pip/Tazo) | Tmp/Sxt | Tetra | Mero |
| C. koseri | 18 | 0 | 100 | 75 | 100 | nt | 100 | 100 | nt | 100 | 100 | 72 | nt | 100 | 100 | nt |
| C. freundii | 16 | 0 | 81 | 0 | 100 | nt | 100 | 100 | nt | 100 | 100 | 100 | nt | 100 | 94 | nt |
| Pantoea (Enterobacter) aerogenes | 12 | 0 | 0 | 0 | 92 | nt | 100 | 100 | nt | 100 | 100 | 8 | nt | 100 | 12 | nt |
| E. cloacae | 13 | 0 | 0 | 0 | 69 | nt | 62 | 62 | nt | 62 | 69 | 15 | nt | 69 | 69 | nt |
| E. coli | 943 | 59 | 84 | 93 | 99 | nt | 95 | 96 | nt | 85 | 85 | 96 | nt | 82 | 81 | nt |
| K. pneumoniae | 138 | 0 | 88 | 85 | 88 | nt | 93 | 89 | nt | 86 | 86 | 25 | nt | 86 | 90 | nt |
| P. mirabilis | 66 | 96 | 99 | 99 | 99 | nt | 99 | 99 | nt | 91 | 92 | 0 | nt | 96 | 0 | nt |
| P. aeruginosa | 26 | nt | nt | nt | 96 | 96 | 100 | 100 | 100 | 77 | nt | nt | 96 | nt | nt | 100 |